CFT7455, a novel IKZF1/3 degrader, demonstrates potent activity in peripheral and CNS models of NHL as a single agent or in combination with clinically approved agents.
Autor: | Thomenius, M. J., Perino, S., Kirby, J., Agafonov, R., Chaturvedi, P., Eron, S., Good, A., Hart, J. A., He, M., Phillips, A., Proia, D. A., Henderson, J. A., Nasveschuk, C., Fisher, S. L., Pollock, R. M. |
---|---|
Předmět: | |
Zdroj: | Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p550-551, 2p |
Databáze: | Complementary Index |
Externí odkaz: |